XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Operating Expenses:        
Research and development $ 11,577 $ 8,497 $ 22,130 $ 13,927
General and administrative 3,101 3,320 6,650 6,863
Total operating expenses 14,678 11,817 28,780 20,790
Loss from operations (14,678) (11,817) (28,780) (20,790)
Other income (expense):        
Grant income 7,311 6,925 12,223 10,351
Other income (expense), net 333 172 577 (443)
Interest expense (7) (6) (17) (16)
Loss on currency translation from liquidation of subsidiary     (195)  
Total other income, net 7,637 7,091 12,588 9,892
Net loss (7,041) (4,726) (16,192) (10,898)
Foreign currency translation adjustment, including reclassifications   (1) 195 3
Total comprehensive loss $ (7,041) $ (4,727) $ (15,997) $ (10,895)
Net loss per share, basic (in dollars per share) $ (0.18) $ (0.16) $ (0.44) $ (0.37)
Net loss per share, diluted (in dollars per share) $ (0.18) $ (0.16) $ (0.44) $ (0.37)
Weighted-average common shares outstanding, basic (in shares) 40,062,954 29,614,822 36,899,112 29,356,144
Weighted-average common shares outstanding, diluted (in shares) 40,062,954 29,614,822 36,899,112 29,356,144